LAHORE: World-renowned US physician and immunologist Dr Anthony Fookie has expressed fears about the effectiveness of COVID-19, a vaccine against the corona virus in South Africa, which appears to be slightly more complex than in the UK.
“Because British scientists say that different conditions in the UK increase its transmissibility compared to wireless, the different forms of South Africa are a bit more complex, which could jeopardize the effectiveness of the vaccine,” said Dr Foki. HIV Research4 (HIVR4P) Conference – International AIDS Society (IAS) Virtual Conference, originally scheduled for last November in Cape Town It is now online in the last week of January and the first week of February.
Dr. Fukui, director of the US National Institute of Allergy and Infectious Diseases (NIAID), has been at the forefront of combating the Covid 19 epidemic since 1984, and believes that the corona virus Wireless with most ECCA antibodies is likely to be obtained much faster than vaccines, which cause a multifunctional reaction. He warned, “If an unicellular antibody unfortunately changes its binding to its mobility, which is more likely to be with the South African mutant than the UK mutant, then we They are very worried.
Dr. Foki says that the current variants of vaccines available so far have no negative effect on the prevention of COVID-19. “However, we are really following it carefully because it is understandable that, with another change, it will have a negative impact on the effectiveness of the vaccine,” Dr. Foki told The News.
In light of Dr. Foki’s revelation, Pakistan needs to be extremely careful about avoiding the threat of South Africa’s variety of vaccines at a time when 14 years later the South African cricket team is ready for a historic home series. Is on tour as foreign teams were barred from coming to Pakistan after 2009 terrorist attack on Sri Lankan cricket team in Lahore.
AVAC (AIDS Vaccine Advocacy Coalition) moderated by Mitchell Warren and Katherine Hankins – Speaking at a meeting titled “Meet the Expert: Anthony Foki, US National Institutes of Health” – Dr. Foki said COVID -19 vaccines did not come. One year but based on a 10 year research platform. “We have decades of experience with coronavirus because 15 to 30 percent of all common colds are caused by coronavirus. For example, in 2002 we had severe acute respiratory syndrome (SARS), Middle East respiratory syndrome. (MERS), and now the third infectious disease is caused by the coronavirus SARS COVID 2, commonly known as COVID-19.
Although research on the COVD-19 vaccine did not begin in early 2019, Dr. Fookie believes that, within a year, these vaccine platforms are fortunately working for us, leading to an epidemic within a year. The disease spread. “So speed was not careless, speed was science,” he said, adding that science has designated vaccine platform technology as a breakthrough for the year 2020.
As soon as Pfizer and Modern are approved by the Food and Drug Administration (FDA), both vaccine platforms show 94 to 95 percent efficacy. “Final trials have confirmed that this vaccine is extremely effective in preventing clinically identifiable disease, and is almost 100 percent effective in preventing modern disease,” he said.
Although the CoVID-19 vaccine prevents clinical disease but does not prevent infection, Dr. Fuki added that it requires a great deal of persistence and asymptomatic carrier testing to determine if it is a virus. Will be transferred to another person. “We are on a monthly paycheck until we follow asymptomatic carriers within a year,” he added.
Dr. Foki said that in addition to symptoms such as the common flu, Covid 19 shows unusual symptoms of loss of smell and taste. He added, “In its severe manifestations, COVID-19 causes severe physical instability in adults as well as causes Multi-System Inflammatory Syndrome (MIS-C) in children, similar to Kawasaki disease.”
Asked how to deal with the skepticism about the COVID-19 vaccine, Dr. Foki said that even in the United States, there is more than 50% denial and hesitation. Therefore, he advised, no one should be blamed for not vaccinating anyone. Instead, he said, one has to explain it through science – the science of vaccine development and approval. “The second way is for public figures to be vaccinated soon against US President Joe Biden, Vice President-elect Kamala Harris and the public.” “A highly effective vaccine is now available, so there is no reason to vaccinate people even in a difficult political environment,” he said. This is a global problem, everyone needs to be vaccinated. “We will not be free from the risk of CoVID-19 unless we get 70 to 85 percent of the flock to be immune.
Dr. Foki said that many companies are preparing to make billions of dollars. He revealed, “We have enough vaccines for the whole world in a year or two. Until then, people need to wear masks, wash their hands and adopt public health measures, which are spreading and achieving.” “Standard Operating Procedures (SOPs) also help avoid imposing complete lockdowns, which can lead to economic hardship and severe COVID-19 fatigue,” he explained. “
Dr. Foucault, entitled “Eradicating AIDS: Sustaining Progress through COVID-19 Infectious Diseases” used simple global figures to illustrate the difference between the two epidemics. In the 40 years since the HIV epidemic began in 1981, a maximum of 76 million people have been infected. In just one year of COVID-19, a staggering 91 million people have contracted the corona virus, while about 2% of those infected with COVID-19 have died, with the highest mortality rate among HIV-infected people. Is. 43%
He said that after the outbreak of the corona virus, people living with HIV in the second infection had direct and indirect consequences of the outbreak.
Under the indirect effects of COVID-19, Dr. Fuki predicted that deaths from HIV, tuberculosis and malaria could increase by 10%, 20% and 36% in five years, respectively. I had COVID-19 before the epidemic. ARV services in 101 countries were reduced by 32% due to disruptions caused by Covid 19. Malaria diagnosis and treatment 46% in 46 countries And in detecting and treating 42% of TB cases in 101 countries.
Although under the direct effects of COVID-19, 51% of people living with HIV, already over 50 years of age, are at high risk because HIV is physically premature. Causes growth, and as a result it is associated with comorbidities. “Apart from the elderly, people of any age can suffer from basic medical conditions such as obesity, smoking and chronic complications, and to some extent immunocompromised,” he said.
Dr. Fuki said that research into the HIV vaccine was recognized to provide a fully viable development of the COVID-19 vaccine, provided such tools for scientific discovery and adherence to principles, and hoped that some The HIV / AIDS epidemic will be realized one day.
“A vaccine usually mimics the body’s innate immunity to a virus, which usually clears up,” he said. “That’s why I predict we could develop the Covid-19 vaccine, because in 98% of cases the immune system clears the virus,” he said. But in HIV, that doesn’t happen. Because we have succeeded in creating immunological capabilities to eradicate smallpox, measles, polio, etc., so too must a vaccine produce an immune response that is better than nature, but difficult to do in the case of HIV. Is.
Dr. Fuki said that science has made great strides around HIV / AIDS since 1981 as the average survival rate has increased by 1-2 years since AIDS was diagnosed in the 1980s and is now predicted. It is possible that a new 20-year-old victim could live another 53 years if treated. Today with appropriate antiretroviral therapy. Therefore, in light of these scientific advances around HIV / AIDS, he said, there is hope and the search for the HIV vaccine will continue with increasing effort and commitment.
Asked if the rapid development of the COVID-19 vaccine provides lessons for the development of the HIV vaccine, Dr. Fuki said that, at the very least, an effective HIV vaccine preventative measure should be implemented. In addition, long-term prevention and treatment capabilities need to be developed. Friendly and according to the world’s population. Then we can move around the HIV curve as we did in the case of many diseases. He concluded, “Soon, we’re going to get Coved 19 in the rearview mirror, but we’re going to have HIV in front of us in the headlights.”